Table 6.
Group | H. pylori | Atrophy | Intestinal metaplasia | Lymphocytes | PMN | Score |
H. pylori+/NSAID- | 2.20 ± 0.44 | 0.60 ± 0.54 | 0.40 ± 0.54 | 1.80 ± 0.83 | 1.20 ± 1.30 | 6.20 ± 2.48a |
H. pylori-/NSAID+ | 0.00 ± 0.00 | 0.40 ± 0.54 | 0.60 ± 1.34 | 1.40 ± 0.89 | 0.20 ± 0.44 | 2.60 ± 2.19 |
H. pylori+/NSAID+ | 1.80 ± 1.09 | 0.80 ± 0.83 | 0.40 ± 0.89 | 2.00 ± 0.70 | 1.40 ± 0.89 | 6.40 ± 3.13 |
H. pylori-/NSAID- | 0.00 ± 0.00 | 0.20 ± 0.44 | 0.20 ± 0.44 | 1.40 ± 0.54 | 0.40 ± 0.54 | 2.20 ± 1.64 |
P = 0.017 vs H. pylori-/NSAID- group. PMN: Polymorphonuclear cells; H. pylori: Helicobacter pylori; NSAID: Non-steroidal anti-inflammatory drugs.